1.7
Impact Factor
Indexed in
Scopus
33 days
Time to First Decision

Dermatopathology, Volume 7, Issue 3

2020 December - 3 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (3)

Select all

Case Report

30 Citations

5,223 Views

7 Pages

Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 Pandemic

Roland Aschoff,
Nick Zimmermann,
Stefan Beissert and
Claudia Günther

Dermatopathology2020, 7(3), 57-63;https://doi.org/10.3390/dermatopathology7030010

4 December 2020

Contemporarily to the new SARS-CoV-2 mediated COVID-19 pandemic, a rise in patients with acral chilblain lesions has been described. They manifest late after mild disease or asymptomatic exposure to SARS-CoV-2. Their pathogenic evolution is currently...

Full Article

Case Report

4 Citations

4,885 Views

4 Pages

Histological Changes Related to Symptomatic Improvement of Spontaneous Keloids Treated with a Low-Dosage Regimen of UVA-1 Phototherapy

Carlos Cuenca-Barrales,
José Aneiros-Fernández,
Israel Pérez-López,
Julia Rodríguez-Pérez,
Ricardo Ruiz-Villaverde and
Jorge Luis Espelt-Otero

Dermatopathology2020, 7(3), 53-56;https://doi.org/10.3390/dermatopathology7030009

3 December 2020

Keloids are a difficult-to-treat disease characterized by an imbalance in mechanisms of tissue reparation. We present the case of a middle-aged woman with spontaneous keloids which histologically and clinically improved after UVA-1 phototherapy treat...

Full Article

Case Report

5 Citations

4,519 Views

5 Pages

Voriconazole-Induced Squamous Cell Carcinoma after Hematopoietic Stem Cell Transplantation Showing Early-Stage Vascular Invasion

Yumi Sawada,
Yasuo Nakai,
Naho Yokota,
Koji Habe,
Akinobu Hayashi and
Keiichi Yamanaka

Dermatopathology2020, 7(3), 48-52;https://doi.org/10.3390/dermatopathology7030008

9 October 2020

Voriconazole is a triazole antifungal agent used for the prevention and treatment of fungal infections in immunocompromised patients. Prolonged voriconazole therapy may induce phototoxicity and lead to the development of malignant neoplasms of the ep...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Dermatopathology - ISSN 2296-3529

Imprint

Download Flyer